Postmortem tissue concentrations of olanzapine

Journal of Analytical Toxicology

Volumn 33, Issue 1, 2009, Pages 15-26

  Vance, Christopher ^a   Mclntyre, Iain M ^a  

^a San Diego County Medical Examiner's Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ANAMNESIS; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG TISSUE LEVEL; HUMAN; LIVER; MASS FRAGMENTOGRAPHY; VITREOUS BODY; ADULT; AGED; CASE REPORT; CAUSE OF DEATH; DIFFERENTIAL DIAGNOSIS; FEMALE; FORENSIC TOXICOLOGY; INTOXICATION; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CAUSE OF DEATH; DIAGNOSIS, DIFFERENTIAL; FEMALE; FORENSIC TOXICOLOGY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; OVERDOSE;

EID: 61949323343     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.1.15     Document Type: Article

References (20)

1. Eli Lilly and Company. Zyprexa Prescribing Informational Material, http://pi.lilly.com/us/zyprexa-pi.pdf, May 2008, PV6240 AMP, pp 7-8.
2. Eli Lilly and Company. Zyprexa Prescribing Informational Material, http://pi.lilly.com/us/zyprexa-pi.pdf, May 2008, PV6240 AMP, pp 1-2.
3. F.P. Bymaster, D.O. Calligaro, J.F. Falcone, R.D. Marsh, N.A. Moore,N.C. Tye, P. Seeman, and D.T. Wong. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsy-chopharmacology 14: 87-96 (1996).
4. Eli Lilly and Company. Zyprexa Prescribing Informational Material, http://pi.lilly.com/us/zyprexa-pi.pdf, May 2008, PV6240 AMP, pp 13-16.
5. Eli Lilly and Company. Zyprexa Prescribing Informational Material, http://pi.lilly.com/us/zyprexa-pi.pdf, May 2008, PV6240 AMP,
6. R. Meatherall and J. Younes. Fatality from olanzapine induced glycemia. J. Forensic Sci. 47(4): 893-896 (2002).
7. B.G. Stephens, D.E. Coleman, and R.C. Baselt. Olanzapine related fatality. J. Forensic Sci. 43(6): 1252-1253 (1998).
8. A.A. Elian. Fatal overdose of olanzapine. Forensic Sci. Int. 91(3): 231-235 (1998).
9. B.S. Levine, S.C. Wu, and J.E. Smialek. Olanzapine concentrations in forensic investigations. Presented at annual meeting of Society of Forensic Toxicologists, Albuquerque, NM, October 8,1998.
10. T.C. Merrick, J.A. Felo, and A.J. Jenkins. Tissue distribution of olanzapine in a postmortem case. Am. J. Forensic Med. Pathol 22(3): 270-274 (2001).
11. E.L. Horakand A.J. Jenkins. Postmortem distribution of olanzapine and citalopram in a drug intoxication. J. Forensic Sci. 50(3): 679-681 (2005).
12. P. Chue and P. Singer. A review of olanzapine-associated toxicity and fatality in overdose. J. Psychiatry Neurosci. 28(4): 253-261 (2003).
13. M.D. Robertson and M.M. McMullin. Olanzapine concentrations in clinical serum and postmortem blood specimens-when does therapeutic become toxic? J. Forensic Sci. 45(2): 418-421 (2000).
14. E.H. Foerster, D. Hatchet, and J.C. Garriott. A rapid comprehensive screening procedure for basic drugs in blood and tissues byas chromatography. J. Anal. Toxicol. 2: 50-55 (1978).
15. 15.C.W. O'Keefe, L.J. Liddicoat, W.R. Johnson, and J.K. Ricksecker Stability of Olanzapine in Stored Blood. Abstracts of the Society of Forensic Toxicologists, 2002.
16. H. Druid and P. Holmgren. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J. Forensic Sci. 42: 79-87 (1997).
17. J. Bidanset, C. Salerno, R. Dettling, et al. A case report involving fluvoxamine in a multi-drug associated death. Presented at the meeting of the Society of Forensic Toxicologists. Puerto Rico, October 12, 1999.
18. C. Hiemke, A. Peled, M. Jabarin, J. Hadjez, H. Weigmann, S. Härtter, I. Modai, M. Ritsner, and H. Silver. Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacoki-netic interactions and clinical effects. J. Clin. Psychopharmacol 22(5): 502-506 (2002).
19. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 7th Ed. Biomedical Publications, Foster City, CA, 2004, p 830.
20. D.J. Pounder and G.R. Jones. Post-mortem drug redistribution-a toxicological nightmare. Forensic Sci. Int. 45(3): 253-263(1990).